Second-Line Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer Who Have Received First-Line Chemotherapy and Bevacizumab
Clinical trial NCT00720512 · TERMINATED
Trial details
- NCT number
- NCT00720512
- Sponsor
- Gruppo Oncologico del Nord-Ovest
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2013-02-01
- Enrollment
- 184
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.